NO20011693L - Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser - Google Patents

Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser

Info

Publication number: NO20011693L
Authority: NO; Norway
Prior art keywords: prevention; treatment; cerebral; carnitines; resveratrol
Prior art date: 1998-10-09

Application number

NO20011693A

Other languages

English (en)

Norwegian (no)

Other versions

NO20011693D0 (no

Inventor

Claudio Cavazza

Original Assignee

Sigma Tau Healthscience Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-09

Filing date

2001-04-04

Publication date

2001-04-04

2001-04-04 Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa

2001-04-04 Publication of NO20011693L publication Critical patent/NO20011693L/no

2001-04-04 Publication of NO20011693D0 publication Critical patent/NO20011693D0/no

Links

230000002265 prevention Effects 0.000 title abstract 2
QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title 1
LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title 1
230000032683 aging Effects 0.000 title 1
230000002490 cerebral effect Effects 0.000 title 1
229940016667 resveratrol Drugs 0.000 title 1
235000021283 resveratrol Nutrition 0.000 title 1
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
LXOPCHVYWBGPND-VOTSOKGWSA-N 4-[(e)-2-phenylethenyl]benzene-1,2,3-triol Chemical group OC1=C(O)C(O)=CC=C1\C=C\C1=CC=CC=C1 LXOPCHVYWBGPND-VOTSOKGWSA-N 0.000 abstract 1
208000018152 Cerebral disease Diseases 0.000 abstract 1
RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
PDHAOJSHSJQANO-OWOJBTEDSA-N Oxyresveratrol Chemical compound OC1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 PDHAOJSHSJQANO-OWOJBTEDSA-N 0.000 abstract 1
-1 alkanoyl L-carnitine Chemical compound 0.000 abstract 1
230000001537 neural effect Effects 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Botany (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

NO20011693A 1998-10-09 2001-04-04 Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser NO20011693D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT1998RM000636A IT1302365B1 (it)	1998-10-09	1998-10-09	Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
PCT/IT1999/000311 WO2000021526A1 (en)	1998-10-09	1999-10-06	Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders

Publications (2)

Publication Number	Publication Date
NO20011693L true NO20011693L (no)	2001-04-04
NO20011693D0 NO20011693D0 (no)	2001-04-04

Family

ID=11406160

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011693A NO20011693D0 (no)	1998-10-09	2001-04-04	Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser

Country Status (27)

Country	Link
US (1)	US6515020B1 (da)
EP (1)	EP1117394B1 (da)
JP (1)	JP4166951B2 (da)
KR (1)	KR20010079981A (da)
CN (1)	CN1323205A (da)
AR (1)	AR020762A1 (da)
AT (1)	ATE249823T1 (da)
AU (1)	AU767492B2 (da)
BR (1)	BR9915918A (da)
CA (1)	CA2344893C (da)
CZ (1)	CZ2001920A3 (da)
DE (1)	DE69911441T2 (da)
DK (1)	DK1117394T3 (da)
EE (1)	EE200100205A (da)
ES (1)	ES2207287T3 (da)
HK (1)	HK1040935A1 (da)
HU (1)	HU229364B1 (da)
IL (1)	IL142046A0 (da)
IS (1)	IS5896A (da)
IT (1)	IT1302365B1 (da)
NO (1)	NO20011693D0 (da)
PL (1)	PL197342B1 (da)
PT (1)	PT1117394E (da)
SK (1)	SK3782001A3 (da)
TN (1)	TNSN99186A1 (da)
TR (1)	TR200100947T2 (da)
WO (1)	WO2000021526A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002047193A (ja) *	2000-07-31	2002-02-12	Sunstar Inc	アレルギー性皮膚炎予防または治療用組成物
WO2002038141A2 (en) *	2000-11-08	2002-05-16	Massachusetts Institute Of Technology	Compositions and methods for treatment of mild cognitive impairment
BRPI0106382B1 (pt) *	2001-03-13	2017-07-11	Universidade Do Estado Do Rio De Janeiro - Uerj	Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions
ATE342044T1 (de) *	2001-08-18	2006-11-15	Cognis Ip Man Gmbh	Wirkstoffmischungen
US20070218151A1 (en) *	2002-03-12	2007-09-20	Universidade Do Estado Do Rio De Janeiro	Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins
US7977049B2 (en) *	2002-08-09	2011-07-12	President And Fellows Of Harvard College	Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
KR100574392B1 (ko) *	2003-02-07	2006-05-02	재단법인서울대학교산학협력재단	신경보호활성을 갖는 신규 페닐환 유도체 및 이를함유하는 약학 조성물
US20050096256A1 (en) *	2003-07-01	2005-05-05	President And Fellows Of Harvard College	Compositions for manipulating the lifespan and stress response of cells and organisms
US20060025337A1 (en) *	2003-07-01	2006-02-02	President And Fellows Of Harvard College	Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
KR100543056B1 (ko) *	2003-11-07	2006-01-20	(주)네추럴에프앤피	신경세포 보호 활성이 있는 포도씨 추출물을 포함하는뇌질환 예방 및 치료용 조성물
CN101247793B (zh)	2003-12-29	2013-04-10	哈佛大学校长及研究员协会	治疗或预防肥胖和胰岛素抗性病症的组合物
US8017634B2 (en)	2003-12-29	2011-09-13	President And Fellows Of Harvard College	Compositions for treating obesity and insulin resistance disorders
ES2245609B1 (es) *	2004-06-18	2007-08-16	Universidad De Barcelona	Nuevo agente terapeutico para el tratamiento de la infertilidad y/o subfertilidad masculina en mamiferos.
WO2006004722A2 (en) *	2004-06-30	2006-01-12	Biomol Research Laboratories, Inc.	Compositions and methods for selectively activating human sirtuins
US20060121137A1 (en) *	2004-12-07	2006-06-08	Hartle Diane K	Muscadine grape pomace in the treatment of intestinal inflammation
CA2595159A1 (en) *	2005-01-13	2006-07-20	Sirtris Pharmaceuticals, Inc.	Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
WO2006138418A2 (en) *	2005-06-14	2006-12-28	President And Fellows Of Harvard College	Improvement of cognitive performance with sirtuin activators
EP2322158B1 (en) *	2005-10-26	2020-06-10	Kao Corporation	Resveratrol and/or grape leaf extract for energy metabolism activation
FR2898493B1 (fr) *	2006-03-16	2008-08-08	Af Consulting	Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation de genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes
US20120016037A1 (en) *	2006-07-24	2012-01-19	Frank Toppo	Method for prevention and treatment of Alzheimers
MX2009008022A (es) *	2007-01-26	2009-12-11	Univ Washington	Metodos y composiciones para tratar neuropatias.
AT506014A1 (de) *	2007-10-24	2009-05-15	Karl Mag Dr Zehethofer	Functional drink
CN102939084A (zh) *	2010-06-16	2013-02-20	希格马托制药工业公司	在用于增加神经组织的神经发生的方法中使用的乙酰基-肉碱
KR101327936B1 (ko) *	2011-07-06	2013-11-13	한국식품연구원	옥시레스베라트롤 이민 유도체를 유효성분으로 함유하는 뇌신경보호 효과를 가지는 조성물
CN102919943A (zh) *	2012-10-26	2013-02-13	郑全辉	保健饮品-葡藤素
CN103877170B (zh) *	2012-12-19	2015-11-04	中国医学科学院药用植物研究所	一种虎杖的乙酸乙酯提取物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4346107A (en) *	1979-02-12	1982-08-24	Claudio Cavazza	Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1276225B1 (it) *	1995-10-17	1997-10-27	Sigma Tau Ind Farmaceuti	Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1283967B1 (it) *	1996-03-29	1998-05-07	Sigma Tau Ind Farmaceuti	Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
AU6141498A (en)	1997-02-04	1998-08-25	John V. Kosbab	Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) *	1997-03-20	1998-12-29	Sigma Tau Ind Farmaceuti	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
CH692837A5 (it) *	1997-07-02	2002-11-29	Lisapharma Spa	Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p
US5904924A (en)	1997-11-04	1999-05-18	Oncologics, Inc.	Green nutritional powder composition
AU4084599A (en) *	1998-05-18	1999-12-06	Oklahoma Medical Research Foundation	Resveratrol inhibition of myeloperoxidase

1998
- 1998-10-09 IT IT1998RM000636A patent/IT1302365B1/it active IP Right Grant
1999
- 1999-10-05 TN TNTNSN99186A patent/TNSN99186A1/fr unknown
- 1999-10-06 CN CN99811952A patent/CN1323205A/zh active Pending
- 1999-10-06 JP JP2000575502A patent/JP4166951B2/ja not_active Expired - Fee Related
- 1999-10-06 SK SK378-2001A patent/SK3782001A3/sk unknown
- 1999-10-06 CZ CZ2001920A patent/CZ2001920A3/cs unknown
- 1999-10-06 WO PCT/IT1999/000311 patent/WO2000021526A1/en not_active Application Discontinuation
- 1999-10-06 KR KR1020017004267A patent/KR20010079981A/ko not_active Application Discontinuation
- 1999-10-06 TR TR2001/00947T patent/TR200100947T2/xx unknown
- 1999-10-06 IL IL14204699A patent/IL142046A0/xx unknown
- 1999-10-06 EP EP99947853A patent/EP1117394B1/en not_active Expired - Lifetime
- 1999-10-06 BR BR9915918-0A patent/BR9915918A/pt not_active Application Discontinuation
- 1999-10-06 DK DK99947853T patent/DK1117394T3/da active
- 1999-10-06 PL PL347209A patent/PL197342B1/pl not_active IP Right Cessation
- 1999-10-06 AU AU61213/99A patent/AU767492B2/en not_active Ceased
- 1999-10-06 EE EEP200100205A patent/EE200100205A/xx unknown
- 1999-10-06 PT PT99947853T patent/PT1117394E/pt unknown
- 1999-10-06 ES ES99947853T patent/ES2207287T3/es not_active Expired - Lifetime
- 1999-10-06 HU HU0104021A patent/HU229364B1/hu unknown
- 1999-10-06 CA CA002344893A patent/CA2344893C/en not_active Expired - Fee Related
- 1999-10-06 US US09/806,454 patent/US6515020B1/en not_active Expired - Fee Related
- 1999-10-06 DE DE69911441T patent/DE69911441T2/de not_active Expired - Lifetime
- 1999-10-06 AT AT99947853T patent/ATE249823T1/de active
- 1999-10-08 AR ARP990105115A patent/AR020762A1/es unknown
2001
- 2001-03-16 IS IS5896A patent/IS5896A/is unknown
- 2001-04-04 NO NO20011693A patent/NO20011693D0/no not_active Application Discontinuation
2002
- 2002-04-17 HK HK02102885.2A patent/HK1040935A1/zh unknown

Also Published As

Publication number	Publication date
JP4166951B2 (ja)	2008-10-15
US6515020B1 (en)	2003-02-04
PT1117394E (pt)	2004-02-27
HUP0104021A3 (en)	2003-12-29
SK3782001A3 (en)	2001-10-08
TNSN99186A1 (fr)	2005-11-10
HUP0104021A2 (hu)	2002-02-28
CN1323205A (zh)	2001-11-21
AU767492B2 (en)	2003-11-13
CZ2001920A3 (cs)	2001-08-15
WO2000021526A1 (en)	2000-04-20
EE200100205A (et)	2002-06-17
CA2344893A1 (en)	2000-04-20
AU6121399A (en)	2000-05-01
JP2002527389A (ja)	2002-08-27
ES2207287T3 (es)	2004-05-16
CA2344893C (en)	2008-07-29
HK1040935A1 (zh)	2002-06-28
DE69911441T2 (de)	2004-07-01
PL197342B1 (pl)	2008-03-31
IS5896A (is)	2001-03-16
PL347209A1 (en)	2002-03-25
IL142046A0 (en)	2002-03-10
ATE249823T1 (de)	2003-10-15
DK1117394T3 (da)	2004-01-26
AR020762A1 (es)	2002-05-29
EP1117394A1 (en)	2001-07-25
TR200100947T2 (tr)	2001-07-23
EP1117394B1 (en)	2003-09-17
DE69911441D1 (de)	2003-10-23
KR20010079981A (ko)	2001-08-22
ITRM980636A1 (it)	2000-04-10
BR9915918A (pt)	2001-08-21
HU229364B1 (en)	2013-11-28
IT1302365B1 (it)	2000-09-05
NO20011693D0 (no)	2001-04-04

Legal Events

Date	Code	Title	Description
2003-06-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20011693L (no)	2001-04-04	Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser
BR9911440A (pt)	2001-03-20	Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa
FI942452A (fi)	1995-06-22	Formuloinnit, jotka sisältävät karotenoideja ja prokarotenoideja, jotka on yhdistetty polyfenoleihin vammojen ehkäisyssä, jotka johtuvat epänormaalista vapaaradikaalituotannosta
DK1481682T3 (da)	2007-11-05	Præparat som indeholder oligosaccharider og probiotika
CA2341973A1 (en)	2000-03-09	Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
NO2007004I1 (no)	2007-04-16	Mycofenolsyre = (E)-6-(1,3-dihydro-4-hydroksy-6-metoksy-7-metyl-3-oksajsobenzofuran-5-yl)-4-, metylheks-4-ensyre
NO986051L (no)	1999-02-23	Anvendelsen av topiramat eller derivater derav for fremstilling av et medikament for behandling av manisk depressive, bipolare forstyrrelser
IL155795A0 (en)	2003-12-23	Combination of drugs (e.g. chlorpromazine and pentamidine) for the treatment of neoplastic disorders
BR9602566A (pt)	1998-10-06	Produto compreendendo um primeiro substrato um circuito de arranjo um circuito multiplexador e uma ou mais estruturas de circuitos integrado
MX9709238A (es)	1998-03-31	Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
BR0209061A (pt)	2004-07-13	Extrator de suco e tubo de orifìcio
WO2002028810A3 (en)	2002-09-26	Retinoids for the treatment of emphysema
ES2192680T3 (es)	2003-10-16	Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
DK0951909T3 (da)	2004-04-05	Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
BR9912703A (pt)	2001-05-02	Composição antioxidante, antiprolìfera, compreendendo uma carnitina e um carotenóide
BR9707210A (pt)	1999-04-06	Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos
HUP0203379A3 (en)	2003-12-29	Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
NO20012457L (no)	2001-07-19	Oral kreatin supplementering for å behandle eller hindre muskelatrofi syndrom
IT1295945B1 (it)	1999-05-28	Integratore dietetico per la prevenzione delle malattie vitreali da invecchiamento
IT1295953B1 (it)	1999-05-28	Scarpa per il mantenimento della salute e l'eliminazione del sudore e procedimento per la sua fabbricazione.
KR960700729A (ko)	1996-02-24	26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)
BR0108823A (pt)	2002-12-10	Composição farmacêutica para o tratamento da doença cerebrovascular cognitiva
AU4952899A (en)	1999-12-20	24,24-difluorinated analogs of 1-alpha,25-dihydroxy vitamin d3
IT1290434B1 (it)	1998-12-03	Integratori dietetici per il trattamento della sindrome menopausale
IT1290436B1 (it)	1998-12-03	Integratori dietetici per il trattamento della sindrome mestruale